Table 4.
Significant correlates of overall cancer mortality-to-incidence rate ratio (MIR) in middle/low- and high-income countries.
| Category | Variable | High-income | Middle/low-income | ||||
|---|---|---|---|---|---|---|---|
| 0.01 ↓ MIR | 95% Confidence Interval | p-value | 0.01 ↓ MIR | 95% Confidence Interval | p-value | ||
| Organization | WHO score | – | – | – | 0.07 | (3.8%, 44.4%) | 0.022 |
| Financial | GDP | $3040 | ($1828, $9091) | 0.004 | – | – | – |
| Resources | THE | $379 | ($248, $800) | <0.001 | – | – | – |
| Healthcare | TEBD | 0.59 | (0.31, 4.93) | 0.027 | – | – | – |
| Infrastructure | Physician Density | – | – | – | −39 | (−74, −26) | <0.001 |
This table shows significant correlates of overall cancer MIR, as well as the increase in each variable needed to cause a 0.01 decrease in cancer MIR. For example, in high-income countries, a $3040 increase in GDP per capita is associated with a 0.01 decrease in overall cancer MIR (p = 0.004). While GDP, THE, and TEBD all showed significant inverse correlations with MIR in high-income countries, THE showed the strongest correlation (highest R and lowest p-value). In middle/low-income countries, only the WHO score correlated with decreased overall cancer MIR, while physician density paradoxically correlated with increased MIR.